Dr Debra Baker joins the firm from Novartis
Polyphor has appointed Debra Baker as its new chief medical and development officer (CMDO) in a role that focuses on clinical strategy and drug development.
Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical operations and services.
She said: “it is an exciting time to join Polyphor and I am very eager to share my experience in drug development in its mission to help patients.”
Giacomo Di Nepi, CEO at Polyphor, added: “I am very happy Debra joins Polyphor. I had the opportunity of working with her at Novartis and really appreciated her leadership, drive and capabilities. Her expertise is immediately applicable to her new role as CMDO of Polyphor and to our clinical programmes,”
Dr Baker succeeds Leon Hootftman, who leaves Polyphor to take a new position.